Tolebrutinib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Tolebrutinib, covering 2024-04-08 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. [Phase 3]